Main Takeaway: "I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ... "If you want to hope for something, hope that Congress is willing to spend a lot more money," the "Mad Money" host said.

Jim Cramer On Vaccine Investors Should Stick With The Major Pharma Companies -

"I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ... "If you want to hope for something, hope that Congress is willing to spend a lot more money," the "Mad Money" host said.

Important details found

  • "I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ...
  • "If you want to hope for something, hope that Congress is willing to spend a lot more money," the "Mad Money" host said.

Why this topic is useful

The goal of this page is to make Jim Cramer On Vaccine Investors Should Stick With The Major Pharma Companies easier to scan, compare, and understand before opening related resources.

Sponsored

Frequently Asked Questions

What should readers check next?

Readers should check related pages, official references, or updated sources when details matter.

Why are related topics included?

Related topics help readers compare nearby references and understand the broader subject.

What is this page about?

This page summarizes Jim Cramer On Vaccine Investors Should Stick With The Major Pharma Companies and connects it with related entries, references, and supporting context.

Visual References

Jim Cramer on vaccine: Investors should stick with the major pharma companies
Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine
Jim Cramer advises investors to 'temper the vaccine hopes'
Jim Cramer on how investors should handle stay-at-home stock slump on Pfizer vaccine news
Jim Cramer: Johnson & Johnson has the best stock of companies developing coronavirus vaccine
Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'
Jim Cramer says there's a buying opportunity in this pharmaceutical company
Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer
Jim Cramer: People ought to calm down on new vaccine results
Jim Cramer on Which AI Stocks Still Have Upside and What to Avoid
Sponsored
View Full Details
Jim Cramer on vaccine: Investors should stick with the major pharma companies

Jim Cramer on vaccine: Investors should stick with the major pharma companies

Read more details and related context about Jim Cramer on vaccine: Investors should stick with the major pharma companies.

Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine

Read more details and related context about Jim Cramer breaks down stocks of companies in the race to develop a coronavirus vaccine.

Jim Cramer advises investors to 'temper the vaccine hopes'

Jim Cramer advises investors to 'temper the vaccine hopes'

"If you want to hope for something, hope that Congress is willing to spend a lot more money," the "Mad Money" host said.

Jim Cramer on how investors should handle stay-at-home stock slump on Pfizer vaccine news

Jim Cramer on how investors should handle stay-at-home stock slump on Pfizer vaccine news

Dow futures surged on the news that data from the coronavirus

Jim Cramer: Johnson & Johnson has the best stock of companies developing coronavirus vaccine

Jim Cramer: Johnson & Johnson has the best stock of companies developing coronavirus vaccine

Read more details and related context about Jim Cramer: Johnson & Johnson has the best stock of companies developing coronavirus vaccine.

Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'

Jim Cramer: Pfizer vaccine news is a 'new chapter for the market'

"I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week," the "Mad Money" ...

Jim Cramer says there's a buying opportunity in this pharmaceutical company

Jim Cramer says there's a buying opportunity in this pharmaceutical company

Read more details and related context about Jim Cramer says there's a buying opportunity in this pharmaceutical company.

Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer

Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer

Read more details and related context about Jim Cramer on how the market is reacting to the government's vaccine deal with Pfizer.

Jim Cramer: People ought to calm down on new vaccine results

Jim Cramer: People ought to calm down on new vaccine results

Read more details and related context about Jim Cramer: People ought to calm down on new vaccine results.

Jim Cramer on Which AI Stocks Still Have Upside and What to Avoid

Jim Cramer on Which AI Stocks Still Have Upside and What to Avoid

Read more details and related context about Jim Cramer on Which AI Stocks Still Have Upside and What to Avoid.